Topic Highlight
Copyright ©2011 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Clin Oncol. May 10, 2011; 2(5): 225-228
Published online May 10, 2011. doi: 10.5306/wjco.v2.i5.225
Recent advances and limitations of surgical treatment for pancreatic cancer
Keiichi Kubota
Keiichi Kubota, Second Department of Surgery, Dokkyo Medical University, 880 Kitakobayashi, Mibu, Tochigi 321-0293 Japan
Author contributions: Kubota K wrote this paper.
Corrspondence to: Keiichi Kubota, MD, PhD, Professor and Chairman, Second Department of Surgery, Dokkyo Medical University, 880 Kitakobayashi, Mibu, Tochigi 321-0293, Japan. kubotak@dokkyomed.ac.jp
Telephone: +81-282-861111 Fax:+81-282-866317
Received: December 24, 2010
Revised: March 8, 2011
Accepted: March 15, 2011
Published online: May 10, 2011
Abstract

Recent advances in surgical treatment for pancreatic cancer have been remarkable. Pancreatoduodenectomy is a standard surgical procedure for cancer of the pancreatic head, and is now indicated even for elderly patients over 80 years of age. Pancreatoduodenectomy with combined resection of the peripancreatic vessels has improved survival, but extended resection including lymph nodes is considered to have no extra survival benefit. Furthermore, laparoscopic resection procedures including pancreatoduodenectomy, distal pancreatectomy, enucleation and central pancreatectomy can now be performed safely. Neoadjuvant or adjuvant chemotherapy using gemcitabine may further improve the surgical outcome. An understanding of the oncological aspects of pancreatic cancer and the development of surgical techniques and chemotherapy may further contribute to improving the outcome of surgery for pancreatic cancer.

Keywords: Chemotherapy; Laparoscopic surgery; Pancreatic cancer; Pancreatoduodenectomy; Pancreatic fistula